BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  NeuroPace Launches New RNS Tablet at 2017 American Epilepsy Society Annual Meeting

  The Tablet will be on display and available for use during hands-on workshops at the American Epilepsy Society’s (AES) Annual Meeting in Washington D.C. from December 1-5 at booth 1101.

  December 1, 2017

   · 

  3 min read
• Biotech Bay

  Amarantus Provides Comprehensive Corporate Update

  The Company is focused on its capital restructuring efforts and restarting operations in Q1 2018.

  December 1, 2017

   · 

  17 min read
• Vilacto Bio Issues Statement About Promotional Activity Concerning Its Common Stock

  The Company is not affiliated in any way with the authors of the promotional activity identified by OTC Markets.

  December 1, 2017

   · 

  3 min read
• Business

  Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board

  Dr. Ali joins a distinguished group of oncologists and immunologists providing their expertise and guidance.

  December 1, 2017

   · 

  2 min read
• Business

  VALNEVA Expands its Commercial Operations and Establishes U.S. Infrastructure

  The fully-owned commercial subsidiary will take direct control of sales and marketing of IXIARO in the U.S. private market with the aim of accelerating sales growth of the vaccine.

  December 1, 2017

   · 

  5 min read
• Fimmic Raises 5M Euros Series A Round to Accelerate Scaling of its Deep Learning AI Cloud for Tissue Diagnostics

  Fimmic announced today that it has closed a €5M investment round to accelerate scaling of its WebMicroscope AI Cloud for tissue diagnostics.

  December 1, 2017

   · 

  1 min read
• 

  FDA

  U.S. FDA Approves Mylan and Biocon’s Ogivri, the First Biosimilar for Trastuzumab, for the Treatment of HER2-Positive Breast and Gastric Cancers

  Ogivri is the first FDA-approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon’s joint portfolio approved in the U.S.

  December 1, 2017

   · 

  12 min read
• Pharm Country

  Cold Spring Harbor Laboratory Release: New Guide Puts 7M More Adults Into High Blood Pressure Risk New Method to Determine Before Surgery Which Prostate Tumors Pose Lethal Threat

  Can we catch potentially lethal cancers earlier to save some of these men?

  December 1, 2017

   · 

  3 min read
• Pharm Country

  Mott Presents Cutting-Edge Technology in Additive Manufacturing at the International Conference on Sintering 2017

  Mott Corporation presented their ground-breaking 3D printing porous technology at the International Conference on Sintering held recently in San Diego, CA from Nov 12-16, 2017.

  December 1, 2017

   · 

  2 min read
• Drug Development

  ASIT Biotech: Newly Published Phase IIb Clinical Results With gp-ASIT+ in the ALLERGY Journal Highlight Outstanding Clinical and Remarkable Immunological Effects

  The results were obtained from a state of the art randomized double-blind, placebo-controlled dose finding study in 198 grass pollen allergic patients.

  December 1, 2017

   · 

  8 min read